The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $13,653,036 in first-year total cost, median $3,581,744.
Most frequent study sections
- Special Emphasis Panel[ZAI1 JBS-A (J1)]4
Most frequent institutions
- SCRIPPS RESEARCH INSTITUTE, THE1
- UNIVERSITY OF ALABAMA AT BIRMINGHAM1
- UNIVERSITY OF PENNSYLVANIA1
- UNIVERSITY OF SOUTHERN CALIFORNIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | In vivo cell engineering for HIV cure.1P01HL183483-01 | CANNON, PAULA MKIEM, HANS-PETER | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $3,693,667 | ZAI1 |
| 2025 | Immunoengineering Durable Control of HIV Replication1P01AI191610-01 | RILEY, JAMES L. | UNIVERSITY OF PENNSYLVANIA, PA | $3,643,653 | ZAI1 |
| 2025 | PlanB2CureHIV (the 'PlanB' consortium)1P01HL183482-01 | VOSS, JAMES EVEN | SCRIPPS RESEARCH INSTITUTE, THE, CA | $3,519,835 | ZAI1 |
| 2025 | Novel cell and gene therapy for HIV cure1P01AI191224-01 | GARCIA-MARTINEZ, J. VICTOR | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $2,795,881 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.